45.66
price down icon1.19%   -0.55
after-market After Hours: 45.73 0.07 +0.15%
loading
Tarsus Pharmaceuticals Inc stock is traded at $45.66, with a volume of 761.77K. It is down -1.19% in the last 24 hours and up +34.73% over the past month. Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
See More
Previous Close:
$46.21
Open:
$45.03
24h Volume:
761.77K
Relative Volume:
1.06
Market Cap:
$1.74B
Revenue:
$17.39M
Net Income/Loss:
$-135.89M
P/E Ratio:
-13.51
EPS:
-3.38
Net Cash Flow:
$-123.00M
1W Performance:
+4.08%
1M Performance:
+34.73%
6M Performance:
+23.91%
1Y Performance:
+185.37%
1-Day Range:
Value
$43.77
$47.06
1-Week Range:
Value
$42.21
$48.60
52-Week Range:
Value
$15.47
$48.60

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
Name
Tarsus Pharmaceuticals Inc
Name
Phone
(949) 409-9820
Name
Address
15440 LAGUNA CANYON ROAD, IRVINE
Name
Employee
244
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TARS's Discussions on Twitter

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-20-23 Initiated Goldman Neutral
Jul-18-23 Initiated William Blair Outperform
May-18-23 Initiated Guggenheim Buy
Aug-01-22 Initiated Barclays Overweight
Dec-21-21 Initiated H.C. Wainwright Buy
Nov-23-21 Initiated Oppenheimer Outperform
Nov-10-20 Initiated BofA Securities Buy
Nov-10-20 Initiated Jefferies Buy
Nov-10-20 Initiated Ladenburg Thalmann Buy
Nov-10-20 Initiated Raymond James Strong Buy
View All

Tarsus Pharmaceuticals Inc Stock (TARS) Latest News

pulisher
04:26 AM

Tarsus Pharmaceuticals appoints new Chief Medical Officer - Investing.com

04:26 AM
pulisher
04:14 AM

Papulopustular Rosacea Market to Expand Significantly by 2034, States DelveInsight Report | Sol-Gel Technologies, Galderma, CollaGenex Pharma, Tarsus Pharma, Pfizer - Barchart

04:14 AM
pulisher
08:33 AM

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewswire

08:33 AM
pulisher
06:46 AM

Here's Why Tarsus Pharmaceuticals (NASDAQ:TARS) Can Manage Its Debt Despite Losing Money - Simply Wall St

06:46 AM
pulisher
03:51 AM

Vanguard Group Inc's Strategic Acquisition in Tarsus Pharmaceuti - GuruFocus.com

03:51 AM
pulisher
Nov 04, 2024

Emerald Mutual Fund Advisers Trust Acquires New Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Nov 04, 2024
pulisher
Nov 01, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 8.5% HigherShould You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains? - MSN

Nov 01, 2024
pulisher
Oct 30, 2024

Tarsus Pharmaceuticals stock hits 52-week high at $42.63 By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 52-Week HighShould You Buy? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Tarsus Pharmaceuticals stock hits 52-week high at $42.63 - Investing.com

Oct 29, 2024
pulisher
Oct 28, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap UpHere's Why - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Allspring Global Investments Holdings LLC Buys 29,465 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Assenagon Asset Management S.A. Raises Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 25, 2024
pulisher
Oct 17, 2024

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY - The Bakersfield Californian

Oct 17, 2024
pulisher
Oct 17, 2024

Tarsus Launches “Your Mitey Problem,” the First - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

Tarsus Pharmaceuticals, Inc Announces the Launch of New Direct-To-Consumer TV campaign for XDEMVY - Marketscreener.com

Oct 17, 2024
pulisher
Oct 13, 2024

Essex Investment Management Co. LLC Invests $3.59 Million in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Was Tarsus Pharmaceuticals Inc (TARS)’s session last reading good? - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

Financial Analysis: Tarsus Pharmaceuticals Inc (TARS)’s Ratios Unveil Key Insights - The Dwinnex

Oct 11, 2024
pulisher
Oct 10, 2024

Taking a look at what insiders are doing to gauge the Tarsus Pharmaceuticals Inc (TARS)’s direction - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $51.60 Consensus Price Target from Analysts - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Papulopustular Rosacea Market Revenue to Expand Significantly - openPR

Oct 09, 2024
pulisher
Oct 09, 2024

Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Simply Wall St

Oct 09, 2024
pulisher
Oct 09, 2024

Millennium Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Recent Insider Activity Suggests Potential Gains for Tarsus Pharmaceuticals Inc (TARS) - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Dimensional Fund Advisors LP Sells 17,931 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 07, 2024
pulisher
Oct 05, 2024

Healthcare of Ontario Pension Plan Trust Fund Decreases Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) versus Genocea Biosciences (NASDAQ:GNCA) Critical Contrast - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5.3%Here's Why - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

(TARS) On The My Stocks Page - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 01, 2024

Scientech Research LLC Invests $289,000 in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Taking the lead: Tarsus Pharmaceuticals Inc (TARS) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Driehaus Capital Management LLC Purchases 203,300 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Reduces Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Sep 29, 2024
pulisher
Sep 27, 2024

Tarsus Pharmaceuticals Inc [TARS] Records 200-Day SMA of $29.59 - Knox Daily

Sep 27, 2024
pulisher
Sep 27, 2024

How did Tarsus Pharmaceuticals Inc (TARS) fare last session? - US Post News

Sep 27, 2024
pulisher
Sep 25, 2024

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024 - ForexTV.com

Sep 25, 2024
pulisher
Sep 24, 2024

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Holdings Decreased by Ensign Peak Advisors Inc - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Tarsus Pharma maintains stock target on ECP feedback - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Federated Hermes Inc. Acquires 11,018 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Rhumbline Advisers Acquires 6,070 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations (NASDAQ:TARS) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 20, 2024

Midday Stock Roundup: Staar Surgical Up - Orange County Business Journal

Sep 20, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals Inc [TARS] Shares Jump Approximately 103.53% Over the Year - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

Tarsus Pharmaceuticals Inc (TARS) expanding its growth trajectory ahead - SETE News

Sep 20, 2024
pulisher
Sep 19, 2024

Trane Technologies (NYSE:TT) Sets New 52-Week High at $382.49 - MarketBeat

Sep 19, 2024

Tarsus Pharmaceuticals Inc Stock (TARS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):